Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure

BMC Developmental Biology

Volumn 7, Issue , 2007, Pages

  Yu, Shan Shan ^a   Wang, Ming ^a   Li, Xin Mei ^a   Chen, Wei Heng ^a   Chen, Ju Tao ^a   Wang, Hui Li ^a   Ruan, Di Yun ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD; TAURINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; PERINATAL PERIOD; PRENATAL PERIOD; RAT; WEANING; ANIMAL; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECT; EMBRYO DEVELOPMENT; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; SYNAPSE; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ANIMALS, NEWBORN; DIETARY SUPPLEMENTS; EMBRYONIC DEVELOPMENT; FEMALE; HIPPOCAMPUS; LEAD; LONG-TERM POTENTIATION; NEURONAL PLASTICITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; SYNAPSES; TAURINE;

EID: 34249987702     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-7-51     Document Type: Article

References (92)

1. Prevalence of blood lead levels >or= 5 micro g/dL among US children 1 to 5 years of age and socioeconomic and demographic factors associated with blood of lead levels 5 to 10 micro g/dL, Third National Health and Nutrition Examination Survey, 1988-1994. SM Bernard MA McGeehin, Pediatrics 2003 112 6 Pt 1 1308 1313 10.1542/peds.112.6.1308 14654602
2. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. RL Canfield CR Henderson Jr. DA Cory-Slechta C Cox TA Jusko BP Lanphear, N Engl J Med 2003 348 16 1517 1526 10.1056/NEJMoa022848 12700371
3. Low-level lead exposure and intelligence in children. JR Nation DH Gleaves, Arch Clin Neuropsychol 2001 16 4 375 388 10.1016/S0887-6177(00)00088-3 14590169
4. Studies of lead exposure and the developing central nervous system: a reply to Kaufman. HL Needleman D Bellinger, Arch Clin Neuropsychol 2001 16 4 359 374 10.1016/S0887-6177(00)00087-1 14590168
5. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. DA Cory-Slechta, Annu Rev Pharmacol Toxicol 1995 35 391 415 7598500
6. Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. SM Lasley ME Gilbert, Neurotoxicology 2000 21 6 1057 1068 11233752
7. Chronic lead exposure accelerates decay of long-term potentiation in rat dentate gyrus in vivo. ME Gilbert CM Mack, Brain Res 1998 789 1 139 149 10.1016/S0006-8993(97)01517-5 9602098
8. Chronic developmental lead exposure increases the threshold for long-term potentiation in rat dentate gyrus in vivo. ME Gilbert CM Mack SM Lasley, Brain Res 1996 736 1-2 118 124 10.1016/0006-8993(96)00665-8 8930316
9. Chronic developmental lead exposure and hippocampal long-term potentiation: biphasic dose-response relationship. ME Gilbert CM Mack SM Lasley, Neurotoxicology 1999 20 1 71 82 10091860
10. The influence of developmental period of lead exposure on long-term potentiation in the adult rat dentate gyrus in vivo. ME Gilbert CM Mack SM Lasley, Neurotoxicology 1999 20 1 57 69 10091859
11. Impairment of long-term potentiation and paired-pulse facilitation in rat hippocampal dentate gyrus following developmental lead exposure in vivo. DY Ruan JT Chen C Zhao YZ Xu M Wang WF Zhao, Brain Res 1998 806 2 196 201 10.1016/S0006-8993(98)00739-2 9739140
12. Subcellular distribution of taurine and cysteinesulphinate decarboxylase in developing rat brain. HC Agrawal AN Davison LK Kaczmarek, Biochem J 1971 122 5 759 763 5129271
13. Amino acids in synaptic vesicles from mammalian cerebral cortex: a reappraisal. JS De Belleroche HF Bradford, J Neurochem 1973 21 2 441 451 10.1111/j.1471-4159.1973.tb04264.x 4724330
14. Physiological actions of taurine. RJ Huxtable, Physiol Rev 1992 72 1 101 163 1731369
15. Taurine as a possible inhibitory transmitter in the cerebellum. WJ McBride RC Frederickson, Fed Proc 1980 39 9 2701 2705 6105098
16. Taurine in development. JA Sturman, Physiol Rev 1993 73 1 119 147 8419963
17. Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid. RG Fariello GT Golden M Pisa, Neurology 1982 32 3 241 245 7199633
18. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. ED French A Vezzani WO Whetsell Jr. R Schwarcz, Adv Exp Med Biol 1986 203 349 362 2947421
19. Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. JW Phillis MH O'Regan, Neurochem Int 2003 43 4-5 461 467 10.1016/S0197-0186(03)00035-4 12742092
20. Modulation of the ischemia-induced taurine release by adenosine receptors in the developing and adult mouse hippocampus. P Saransaari SS Oja, Neuroscience 2000 97 3 425 430 10.1016/S0306-4522(00)00034-8 10828525
21. The role of taurine and glutamate during early postnatal cerebellar development of normal and weaver mutant mice. E Trenkner, Adv Exp Med Biol 1990 268 239 244 1981644
22. Protection by a taurine supplemented diet from lead-induced deficits of long-term potentiation/depotentiation in dentate gyrus of rats in vivo. DM Zhu M Wang JQ She K Yu DY Ruan, Neuroscience 2005 134 1 215 224 10.1016/j. neuroscience.2005.03.011 15953688
23. A pilot study of blood lead levels and neurobehavioral function in children living in Chennai, India. DC Bellinger H Hu K Kalaniti N Thomas P Rajan S Sambandam P Ramaswamy K Balakrishnan, Int J Occup Environ Health 2005 11 2 138 143 15875889
24. Early behavioral effects of lead perinatal exposure in rat pups. M De Marco R Halpern HM Barros, Toxicology 2005 211 1-2 49 58 10.1016/j.tox.2005.02. 007 15863247
25. Early exposure to lead and neuropsychological outcome in adolescence. MD Ris KN Dietrich PA Succop OG Berger RL Bornschein, J Int Neuropsychol Soc 2004 10 2 261 270 10.1017/S1355617704102154 15012846
26. Reduced intellectual development in children with prenatal lead exposure. L Schnaas SJ Rothenberg MF Flores S Martinez C Hernandez E Osorio SR Velasco E Perroni, Environ Health Perspect 2006 114 5 791 797 16675439
27. The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. GA Wasserman X Liu D Popovac P Factor-Litvak J Kline C Waternaux N LoIacono JH Graziano, Neurotoxicol Teratol 2000 22 6 811 818 10.1016/S0892-0362(00)00106-9 11120386
28. Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. HL Needleman CA Gatsonis, Jama 1990 263 5 673 678 10.1001/jama.263.5. 673 2136923
29. Lead exposure and motor functioning in 4(1/2)-year-old children: the Yugoslavia prospective study. GA Wasserman A Musabegovic X Liu J Kline P Factor-Litvak JH Graziano, J Pediatr 2000 137 4 555 561 10.1067/mpd.2000.109111 11035838
30. Combined administration of taurine and meso 2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats. SJ Flora M Pande S Bhadauria GM Kannan, Hum Exp Toxicol 2004 23 4 157 166 10.1191/0960327104ht432oa 15171566
31. Molecular mechanisms of lead neurotoxicity. J Bressler KA Kim T Chakraborti G Goldstein, Neurochem Res 1999 24 4 595 600 10.1023/A:1022596115897 10227691
32. Effects of exposure to lead on selected biochemical and haematological variables. BM Solliway A Schaffer H Pratt S Yannai, Pharmacol Toxicol 1996 78 1 18 22 8685081
33. Lead and cadmium in maternal blood, umbilical cord blood, amniotic fluid and placenta of cows and buffaloes after foetal death (abortion) and after normal parturition. S Kaur, Sci Total Environ 1989 79 3 287 290 10.1016/0048-9697(89)90344-6 2727677
34. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. L Struzynska M Walski R Gadamski B Dabrowska-Bouta U Rafalowska, Mol Chem Neuropathol 1997 31 3 207 224 9336764
35. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Q Wang W Luo W Zheng Y Liu H Xu G Zheng Z Dai W Zhang Y Chen J Chen, Toxicol Appl Pharmacol 2007 219 1 33 41 10.1016/j.taap.2006.11.035 17234227
36. Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood-placenta barrier. T Kitano H Iizasa IW Hwang Y Hirose T Morita T Maeda E Nakashima, Biol Pharm Bull 2004 27 6 753 759 10.1248/bpb.27.753 15187410
37. Use of an in vitro system to study the effects of lead on astrocyte-endothelial cell interactions: a model for studying toxic injury to the blood-brain barrier. AM Gebhart GW Goldstein, Toxicol Appl Pharmacol 1988 94 2 191 206 10.1016/0041-008X(88)90261-X 2898824
38. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. LE Kerper PM Hinkle, Toxicol Appl Pharmacol 1997 146 1 127 133 10.1006/taap.1997.8234 9299604
39. Role of osmoregulation in the actions of taurine. S Schaffer K Takahashi J Azuma, Amino Acids 2000 19 3-4 527 546 10.1007/s007260070004 11140357
40. The in vivo and in vitro protective properties of taurine. JA Timbrell V Seabra CJ Waterfield, Gen Pharmacol 1995 26 3 453 462 7789717
41. Taurine: biological update. CE Wright HH Tallan YY Lin GE Gaull, Annu Rev Biochem 1986 55 427 453 10.1146/annurev.bi.55.070186.002235 3527049
42. Antioxidant effect of taurine against lead-induced oxidative stress. H Gurer H Ozgunes E Saygin N Ercal, Arch Environ Contam Toxicol 2001 41 4 397 402 10.1007/s002440010265 11598776
43. Taurine as a micronutrient in development and regeneration of the central nervous system. L Lima F Obregon S Cubillos F Fazzino I Jaimes, Nutr Neurosci 2001 4 6 439 443 11843263
44. Protective effect of taurine and zinc on peroxidation-induced damage in photoreceptor outer segments. H Pasantes-Morales C Cruz, J Neurosci Res 1984 11 3 303 311 10.1002/jnr.490110310 6737519
45. Histochemical localization of zinc in the feline tapetum. Effect of taurine depletion. JA Sturman GY Wen HM Wisniewski KC Hayes, Histochemistry 1981 72 3 341 350 10.1007/BF00501776 7298380
46. Short-Term Changes in Synaptic Efficacy. KL Magleby, New York, Wiley 1987 2448743
47. Short-term synaptic plasticity. RS Zucker, Annu Rev Neurosci 1989 12 13 31 10.1146/annurev.ne.12.030189.000305 2648947
48. Role of presynaptic calcium ions and channels in synaptic facilitation and depression at the squid giant synapse. MP Charlton SJ Smith RS Zucker, J Physiol 1982 323 173 193 6284915
49. The timing of calcium action during neuromuscular transmission. B Katz R Miledi, J Physiol 1967 189 3 535 544 6040160
50. Relationship between presynaptic calcium current and postsynaptic potential in squid giant synapse. R Llinas IZ Steinberg K Walton, Biophys J 1981 33 3 323 351 6261850
51. Differential regulation of paired-pulse plasticity following LTP in the dentate gyrus. BR Christie WC Abraham, Neuroreport 1994 5 4 385 388 8003660
52. Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. T Manabe DJ Wyllie DJ Perkel RA Nicoll, J Neurophysiol 1993 70 4 1451 1459 7904300
53. Evidence that changes in presynaptic calcium currents are not responsible for long-term potentiation in hippocampus. D Muller G Lynch, Brain Res 1989 479 2 290 299 10.1016/0006-8993(89)91631-4 2924160
54. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. PE Schulz EP Cook D Johnston, J Neurosci 1994 14 9 5325 5337 7916043
55. Residual free calcium is not responsible for facilitation of neurotransmitter release. JA Blundon SN Wright MS Brodwick GD Bittner, Proc Natl Acad Sci U S A 1993 90 20 9388 9392 8105475 10.1073/pnas.90.20.9388
56. Homosynaptic facilitation of transmitter release in crayfish is not affected by mobile calcium chelators: implications for the residual ionized calcium hypothesis from electrophysiological and computational analyses. JL Winslow SN Duffy MP Charlton, J Neurophysiol 1994 72 4 1769 1793 7823101
57. Long-term potentiation of exogenous glutamate responses at single dendritic spines. AA Bagal JP Kao CM Tang SM Thompson, Proc Natl Acad Sci U S A 2005 102 40 14434 14439 16186507 10.1073/pnas.0501956102
58. The alpha-Ca2+/calmodulin kinase II: a bidirectional modulator of presynaptic plasticity. PF Chapman BG Frenguelli A Smith CM Chen AJ Silva, Neuron 1995 14 3 591 597 10.1016/0896-6273(95)90315-1 7695905
59. Tyrosine phosphatases regulate AMPA receptor trafficking during metabotropic glutamate receptor-mediated long-term depression. PR Moult CM Gladding TM Sanderson SM Fitzjohn ZI Bashir E Molnar GL Collingridge, J Neurosci 2006 26 9 2544 2554 10.1523/JNEUROSCI.4322-05.2006 16510732
60. Postsynaptic injection of CA2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. JH Wang PT Kelly, Neuron 1995 15 2 443 452 10.1016/0896-6273(95)90048-9 7646896
61. Regulation of synaptic facilitation by postsynaptic Ca2+/CaM pathways in hippocampal CA1 neurons. JH Wang PT Kelly, J Neurophysiol 1996 76 1 276 286 8836224
62. Hippocampal plasticity induced by primed burst, but not long-term potentiation, stimulation is impaired in area CA1 of aged Fischer 344 rats. CI Moore MD Browning GM Rose, Hippocampus 1993 3 1 57 66 10.1002/hipo.450030106 8364683
63. Ca2+/calmodulin-mediated neurotransmitter release and neurobehavioural deficits following lead exposure. KD Gill V Gupta R Sandhir, cell biochemistry and function 2003 21 345 353 10.1002/cbf.1030
64. Multisite interactions between Pb2+ and protein kinase C and its role in norepinephrine release from bovine adrenal chromaffin cells. JL Tomsig JB Suszkiw, J Neurochem 1995 64 6 2667 2673 7760046
65. Effects of chronic lead exposure on short-term and long-term depression in area CA1 of the rat hippocampus in vivo. DY Ruan KF Yan SY Ge YZ Xu JT Chen M Wang, Chemosphere 2000 41 1-2 165 171 10.1016/S0045-6535(99)00406-3 10819196
66. Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. L Aniksztejn Y Ben-Ari, Nature 1991 349 6304 67 69 10.1038/349067a0 1845914
67. Two components of long-term potentiation induced by different patterns of afferent activation. LM Grover TJ Teyler, Nature 1990 347 6292 477 479 10.1038/347477a0 1977084
68. Ca2+ entry via postsynaptic voltage-sensitive Ca2+ channels can transiently potentiate excitatory synaptic transmission in the hippocampus. DM Kullmann DJ Perkel T Manabe RA Nicoll, Neuron 1992 9 6 1175 1183 10.1016/0896-6273(92)90075-O 1361129
69. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. RC Malenka RA Nicoll, Trends Neurosci 1993 16 12 521 527 10.1016/0166-2236(93)90197-T 7509523
70. Thapsigargin blocks long-term potentiation induced by weak, but not strong tetanisation in rat hippocampal CA1 neurons. T Behnisch KG Reymann, Neurosci Lett 1995 192 3 185 188 10.1016/0304-3940(95)11641-9 7566646
71. Thapsigargin blocks the induction of long-term potentiation in rat hippocampal slices. J Harvey GL Collingridge, Neurosci Lett 1992 139 2 197 200 10.1016/0304-3940(92)90551-H 1319014
72. Lead inhibited N-methyl-D-aspartate receptor-independent long-term potentiation involved ryanodine-sensitive calcium stores in rat hippocampal area CA1. XM Li Y Gu JQ She DM Zhu ZD Niu M Wang JT Chen LG Sun DY Ruan, Neuroscience 2006 139 2 463 473 10.1016/j.neuroscience.2005.12.033 16457957
73. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. VN Adonaylo PI Oteiza, Toxicology 1999 135 2-3 77 85 10.1016/S0300- 483X(99)00051-7 10463764
74. Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration. DA Cory-Slechta M Garcia-Osuna JT Greenamyre, Behav Brain Res 1997 85 2 161 174 10.1016/S0166-4328(96)00174-X 9105573
75. Biochemical evidence of an interaction of lead at the zinc allosteric sites of the NMDA receptor complex: effects of neuronal development. TR Guilarte RC Miceli DA Jett, Neurotoxicology 1995 16 1 63 71 7603646
76. Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons. H Ujihara EX Albuquerque, J Pharmacol Exp Ther 1992 263 2 868 875 1432703
77. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. P Saransaari SS Oja, Neuroscience 1997 79 3 847 854 10.1016/S0306-4522(97)00038-9 9219947
78. Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. A Schurr MT Tseng CA West BM Rigor, Life Sci 1987 40 21 2059 2066 10.1016/0024-3205(87)90098-1 3586851
79. The effects of taurine on Ca2+ uptake by the sarcoplasmic reticulum and Ca2+ sensitivity of chemically skinned rat heart. DS Steele GL Smith DJ Miller, J Physiol 1990 422 499 511 2352190
80. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons. LM Suarez JM Solis, Eur J Neurosci 2006 24 2 405 418 10.1111/j.1460-9568.2006.04911.x 16836643
81. Phencyclidine-binding sites in mouse cerebral cortex during development and ageing: effects of inhibitory amino acids. P Saransaari SS Oja, Mech Ageing Dev 1993 68 1-3 125 136 10.1016/0047-6374(93)90145-H 8350653
82. Taurine and osmoregulation: taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration. H Trachtman R Barbour JA Sturman L Finberg, Pediatr Res 1988 23 1 35 39 10.1203/00006450-198801000-00008 3340441
83. Release of GABA and taurine from brain slices. P Saransaari SS Oja, Prog Neurobiol 1992 38 5 455 482 10.1016/0301-0082(92)90046-H 1589578
84. Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. M Mori BH Gahwiler U Gerber, J Physiol 2002 539 Pt 1 191 200 10.1113/jphysiol.2001.013147 11850512
85. Taurine-evoked chloride current and its potentiation by intracellular Ca2+ in immature rat hippocampal CA1 neurons. ZY Wu TL Xu, Amino Acids 2003 24 1-2 155 161 12624748
86. Quantitative and qualitative changes in AMPA receptor expression during spinal cord development. MW Jakowec AJ Fox LJ Martin RG Kalb, Neuroscience 1995 67 4 893 907 10.1016/0306-4522(95)00026-F 7675212
87. Taurine as osmoregulator and neuromodulator in the brain. SS Oja P Saransaari, Metab Brain Dis 1996 11 2 153 164 10.1007/BF02069502 8776717
88. Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. M Malcangio A Bartolini C Ghelardini F Bennardini P Malmberg-Aiello F Franconi A Giotti, Psychopharmacology (Berl) 1989 98 3 316 320 10.1007/BF00451681 2501810
89. The role of taurine in the survival and function of cerebellar cells in cultures of early postnatal cat. E Trenkner JA Sturman, Int J Dev Neurosci 1991 9 1 77 88 10.1016/0736-5748(91)90075-W 1673044
90. Review of some actions of taurine on ion channels of cardiac muscle cells and others. H Satoh N Sperelakis, Gen Pharmacol 1998 30 4 451 463 10.1016/S0306-3623(97)00309-1 9522160
91. A synaptic model of memory: long-term potentiation in the hippocampus. TV Bliss GL Collingridge, Nature 1993 361 6407 31 39 10.1038/361031a0 8421494
92. Guanidinoethane sulfonate and the disposition of dietary taurine in the rat. RJ Huxtable, J Nutr 1982 112 12 2293 2300 7143111